Betaseron for multiple sclerosis. Implications for therapeutics.
Rudick
R A
RA
D017326:Clinical Trials, Phase III as Topic / Q000191:economics / Q000592:standards; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000008:administration & dosage / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000191:economics / Q000592:standards
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a